A newly disclosed use-after-free in the Linux kernel's epoll code, CVE-2026-46242, lets an unprivileged user get root on ...

The FDA expands approval of Skyrizi (risankizumab-rzaa) for pediatric patients aged 6 years and older with moderate to severe plaque psoriasis or active psoriatic arthritis.

From U.S. v. Virginia, decided yesterday by Judge Robert Payne (E.D. Va.); these conclusions played a role in the ...

If your agentic AI project is failing, your problem is likely that you treated the integration work as somebody else's issue ...

The following is the full transcript of an interview with former CDC chief medical officer Dr. Debra Houry, a portion of which aired on "Face the Nation with Margaret Brennan" on July 5, 2026. This ...

Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis ...

The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient ...

ALBUQUERQUE, N.M. (KRQE) – They’re hard-to-miss, mysterious symbols, now blanketing a downtown wall. However, those symbols are meant to help people figure out where things are in downtown Albuquerque ...

RelabotulinumtoxinA is a liquid neuromodulator designed to deliver rapid clinical improvement in glabellar and lateral canthal lines.

Several new laws go into effect in California on July 1. Here's what you need know about food labels, streaming ads and more.

Several new laws go into effect in California on July 1. Here's what you need know about phone-free schools, gun regulation ...

VulNow B.V., a predictive software supply chain risk intelligence platform, today announced its formal appointment as a CVE™ (Common Vulnerabilities and Exposures) Numbering Authority (CNA) under the ...